Current Assets
Available For Sale Securities Debt Securities Current
Bristol-Myers Squibb Available For Sale Securities Debt Securities Current increased by 96.6% to $912.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.6%, from $907.00M to $912.00M. Over 3 years (FY 2022 to FY 2025), Available For Sale Securities Debt Securities Current shows an upward trend with a 52.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2022
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase suggests higher liquidity and a conservative cash management strategy, while a decrease may indicate cash deployment for operations or acquisitions.
Detailed definition
This represents the portion of a company's investment portfolio consisting of debt securities that are expected to be so...
Peer comparison
Common among large-cap pharmaceutical firms maintaining significant cash reserves for R&D and M&A activities.
Metric ID:
current_assets_available_for_sale_securities_debt_securi_87ec82Historical Data
11 periods
| Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $130.00M | $816.00M | $340.00M | $360.00M | $204.00M | $513.00M | $907.00M | $1.00B | $776.00M | $464.00M | $912.00M |
| QoQ Change | — | +527.7% | -58.3% | +5.9% | -43.3% | +151.5% | +76.8% | +10.7% | -22.7% | -40.2% | +96.6% |
| YoY Change | — | +527.7% | — | — | — | -37.1% | +166.8% | +178.9% | +280.4% | -9.6% | +0.6% |
Range$130.00M – $1.00B
CAGR+118.0%
Avg YoY Growth+158.2%
Median YoY Growth+166.8%
Available For Sale Securities Debt Securities Current at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's available for sale securities debt securities current?
- Bristol-Myers Squibb (BMY) reported available for sale securities debt securities current of $912.00M in Q1 2026.
- How has Bristol-Myers Squibb's available for sale securities debt securities current changed year-over-year?
- Bristol-Myers Squibb's available for sale securities debt securities current increased by 0.6% year-over-year, from $907.00M to $912.00M.
- What is the long-term trend for Bristol-Myers Squibb's available for sale securities debt securities current?
- Over 3 years (2022 to 2025), Bristol-Myers Squibb's available for sale securities debt securities current has grown at a 52.8% compound annual growth rate (CAGR), from $130.00M to $464.00M.
- What does available for sale securities debt securities current mean?
- Short-term investments in debt securities that the company intends to sell within a year.